Chemfab Alka.
Chemfab Alka. Q3 FY26: Revenue ₹62.17 Cr, PAT ₹15.22 Cr
Q3 FY26 investor presentation: what the company reported on revenue, margins and projects.
Based on Chemfab Alka.'s Q3 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentationreports, not management guidance.
The short version
Overall (Q3FY26 vs Q3FY25): - Revenue from Operation: ₹62.17 crore, down 21.51% YoY (₹79.21 crore in Q3FY25) - Operational EBITDA: ₹5.17 crore, down 64.32% YoY - EBITDA Margin: 8.32%, do Quarterly EBITDA (Operational + Profit & Loss summary): - Q3FY26 Operational EBITDA: ₹5.17 crore (down 64.32% YoY from ₹14.49 crore in Q3FY25) - Chlor Alkali Segment EBITDA: ₹1.77 crore (down 3.8% YoY) - OPVC Segment EBITDA: ₹3.40 crore (down 73.12% YoY from ₹12.65 crore) - Operating EBITDA Margin: - Overall: 8.32% (down 998 bps YoY from 18.29%) - Chlor Alkali Segment: 3.72% (down 39 bps YoY) - OPVC Segment: 23.21% (down 1,350 bps YoY) - Profit After Tax (PAT): - Standalone FY25 PAT: ₹15.22 crore (YoY figures not quarter specific) - Margin Outlook: - The presentation states that global caustic prices have likely bottomed out providing a stable base for recovery.
From Chemfab Alka.'s Q3 FY26 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- Overall (Q3FY26 vs Q3FY25):
- Revenue from Operation: ₹62.17 crore, down 21.51% YoY (₹79.21 crore in Q3FY25)
- Operational EBITDA: ₹5.17 crore, down 64.32% YoY
- EBITDA Margin: 8.32%, down 998 bps YoY
- Chlor Alkali Segment (Q3FY26 vs Q3FY25):
- Revenue: ₹47.52 crore, up 6.19% YoY (₹44.75 crore)
- Operational EBITDA: ₹1.77 crore, down 3.80% YoY
- EBITDA Margin: 3.72%, slightly down YoY
- ECU Realisations improved sequentially to ₹38,500/MT from ₹36,700/MT in previous quarter
- OPVC Pipes Segment (Q3FY26 vs Q3FY25):
- Revenue: ₹14.65 crore, down 57.49% YoY (₹34.46 crore)
- Operational EBITDA: ₹3.40 crore, down 73.12% YoY
- Outlook:
- Gradual improvement and stronger performance expected in coming quarters as JJM funding resumes
2 more points from Chemfab Alka.'s call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Chemfab Alka. said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- ₹60 crore invested in Chlor-Alkali technology modernization to improve power efficiency; completed commissioning on 30 Dec 2025; expected to deliver cost efficiencies and higher volumes by Q3FY26.
- ₹15 crore invested in hybrid power project under SPV; commissioning expected in Q4FY26 with ₹15 crore annual power cost savings; currently awaiting final transmission clearance.
- OPVC Pipes capacity expansion from 14,000 TPA (FY25) to 23,000 TPA (FY26) with 7 operational lines in Sri City by Q4FY26; cumulative capex of ₹30-₹70 crore per line:
- Line 4: ₹70 crore (FY24-25)
- Line 5: ₹27 crore (Q2FY26)
- Line 6: ₹28 crore (Q3FY26)
- Line 7: ₹30 crore (Q4FY26)
2 more points from Chemfab Alka.'s call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Chemfab Alka. said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Chemfab Alka.'s call on order book
Pro opens every point from 15K+ earnings calls
Chemfab Alka. — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹75 Cr, net profit ₹0 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Chemfab Alka.'s management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Neochem Bio Solutions Ltd (Q3 FY26)
Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and
- Thirumalai Chemicals Ltd (Q3 FY26)
Q3 FY26 Revenue from Operations (INR Cr):** . Key investor presentation takeaways from Thirumalai Chemicals Ltd's Q3 FY26 investor presentation — and how it ran
- Jubilant Agri & Consumer Products Ltd (Q3 FY26)
Q3 FY26 Revenue from Operations: INR 4,510 million, up 13% YoY from INR 3,975 million in Q3 FY25 (Page 20). Key investor presentation takeaways from Jubilant Ag
- Galaxy Surfactants Ltd (Q3 FY26)
. Key concall takeaways from Galaxy Surfactants Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
Arthneeti Pro · Annual
Chemfab Alka. and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Chemfab Alka. Q3 FY26 results?
Overall (Q3FY26 vs Q3FY25): - Revenue from Operation: ₹62.17 crore, down 21.51% YoY (₹79.21 crore in Q3FY25) - Operational EBITDA: ₹5.17 crore, down 64.32% YoY - EBITDA Margin: 8.32%, do Quarterly EBITDA (Operational + Profit & Loss summary): - Q3FY26 Operational EBITDA: ₹5.17 crore (down 64.32% YoY from ₹14.49 crore in Q3FY25) - Chlor Alkali Segment EBITDA: ₹1.77 crore (down 3.8% YoY) - OPVC Segment EBITDA: ₹3.40 crore (down 73.12% YoY from ₹12.65 crore) - Operating EBITDA Margin: - Overall: 8.32% (down 998 bps YoY from 18.29%) - Chlor Alkali Segment: 3.72% (down 39 bps YoY) - OPVC Segment: 23.21% (down 1,350 bps YoY) - Profit After Tax (PAT): - Standalone FY25 PAT: ₹15.22 crore (YoY figures not quarter specific) - Margin Outlook: - The presentation states that global caustic prices have likely bottomed out providing a stable base for recovery.
What is Chemfab Alka. share price analysis?
Chemfab Alka. currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹473 Cr. Investors should review the full earnings analysis for detailed insights.
Is Chemfab Alka. planning capital expenditure?
₹60 crore invested in Chlor-Alkali technology modernization to improve power efficiency; completed commissioning on 30 Dec 2025; expected to deliver cost efficiencies and higher volumes by Q3FY26.
Keep Chemfab Alka. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.